Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 0 | 0 | 693 | 181 | 215 |
| Gross Profit | 0 | 0 | 690 | 180 | 220 |
| Operating Expenses | 3,000 | 2,710 | 3,050 | 1,790 | 1,980 |
| Operating Income | -3,000 | -2,710 | -2,357 | -1,609 | -1,765 |
| Interest Expense | 120 | 90 | 50 | 50 | 70 |
| Other Income | 90 | 210 | 137 | 79 | 65 |
| Pre-tax Income | -3,030 | -2,590 | -2,270 | -1,580 | -1,770 |
| Net Income Continuous | -3,026 | -2,593 | -2,279 | -1,580 | -1,604 |
| Net Income | $-3,026 | $-2,593 | $-2,279 | $-1,580 | $-1,604 |
| EPS Basic Total Ops | -786,792.00 | -590,096.20 | -524,527.90 | -327,832.20 | -393,391.60 |
| EPS Basic Continuous Ops | -786,792.00 | -590,096.20 | -524,527.90 | -327,832.20 | -393,391.60 |
| EPS Diluted Total Ops | -786,792.00 | -590,096.20 | -524,527.90 | -327,832.20 | -393,391.60 |
| EPS Diluted Continuous Ops | -786,792.00 | -590,096.20 | -524,527.90 | -327,832.20 | -393,391.60 |
| EBITDA(a) | $-2,960 | $-2,680 | $-2,317 | $-1,589 | $-1,745 |